Who
Robert Lawrence Brainin
CEO
Company insider
Files Form 4 as: CEO, Champions Oncology.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Nov 2021
- Last trade
- 16 Jul 2025
- Last filed
- 30 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.8M225,000 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $488K62,500 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $488K62,500 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.8M225,000 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $488K62,500 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $488K62,500 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.2M150,000 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $780K100,000 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $780K100,000 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.2M150,000 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $780K100,000 at $7.80 | filing |
| 16 Jul 2025filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $780K100,000 at $7.80 | filing |
| 12 Nov 2024filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $107K23,030 at $4.64 | filing |
| 12 Nov 2024filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $107K23,030 at $4.64 | filing |
| 3 Nov 2023filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $105K19,070 at $5.51 | filing |
| 3 Nov 2023filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $105K19,070 at $5.51 | filing |
| 1 Nov 2022filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $99K14,130 at $7.00 | filing |
| 1 Nov 2022filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $99K14,130 at $7.00 | filing |
| 5 Nov 2021filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $100K9,901 at $10.10 | filing |
| 5 Nov 2021filed 30 Jan 2026 | CSBR Champions Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $100K9,901 at $10.10 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.